Qrono Inc. is focused on advancing immunotherapy through innovative research and development of new therapies. The company is particularly dedicated to harnessing the potential of Antigen Presenting Cells (APCs), which play a crucial role in the immune response by presenting antigens to T cells. This approach aims to enhance the body’s ability to recognize and combat diseases, particularly cancer, by leveraging the natural mechanisms of the immune system.

In addition to their work with APCs, Qrono Inc. is likely engaged in a range of scientific investigations and clinical applications that explore the efficacy and safety of their therapies. The emphasis on cutting-edge research suggests that the company is committed to developing novel treatment options that could significantly improve patient outcomes in immunotherapy. Their ongoing efforts in the lab reflect a strong dedication to innovation in the field of cancer treatment and immune modulation.

United States

Qrono Inc is working on new immunotherapies using our Eloquent platform to target antigen presenting cells and macrophages.  Sign up on our website for updates.

Qrono Inc.

Company Details